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Abstract
In the critically ill, metabolic acidosis is a common observation and,
in clinical practice, the cause of this derangement is often multi-
factorial. Various measures are often employed to try and
characterise the aetiology of metabolic acidosis, the most popular
of which is the anion gap. The purpose of the anion gap can be
perceived as a means by which the physician is alerted to the
presence of unmeasured anions in plasma that contribute to the
observed acidosis. In many cases, the causative ion may be easily
identified, such as lactate, but often the causative ion(s) remain
unidentified, even after exclusion of the ‘classic’ causes. We
describe here the various attempts in the literature that have been
made to address this observation and highlight recent studies that
reveal potential sources of such hitherto unmeasured anions.
Introduction
Metabolic acidosis remains a common problem in acute
medicine and is frequently encountered on the intensive care
unit (ICU) [1-3]. Although many ‘classic’ causes of metabolic
acidosis are known, including diabetic ketoacidosis, lactic
acidosis and the ingestion of acid-generating poisons, the
origin is often multifactorial and, indeed, often cannot be
ascribed solely to such ‘classic’ causes or a single causative
anion. In such cases, the source of the acidosis remains
unidentified or unmeasured. For example, given that
hydroxybutyrate is seldom measured, diabetic ketoacidosis is,
strictly speaking, an example of acidosis associated with
large quantities of an unmeasured anion, although in practice
its concentration is regularly inferred. Similarly, it is only in the
past 15 years or so that prompt and repeatable measurement
of arterial blood lactate has become commonplace. Prior to
this, lactic acidosis could also reasonably be considered to
represent the presence of an unmeasured anion.
One of the earliest tools for addressing the potential aetiology
of metabolic acidosis is that of the anion gap, which even in
its simplest form helps to characterise many cases of
metabolic acidosis. This measure has undergone various
refinements over the years but one of its purposes is to alert
the physician to the presence of unmeasured ions in plasma
[4-7]. Those studying critically ill patients with metabolic
acidosis have been aware that such a simple categorisation
is often an inadequate description of the metabolic state of
these patients. In lactic acidosis, for example, there is often a
significant discrepancy between the blood lactate
concentration and the base deficit and, more tellingly, when
calculations are made during bicarbonate-based haemo-
filtration, it is apparent that significant quantities of acid other
than lactic acid are being titrated by the administered
bicarbonate. This has given rise to the concept of the
‘unmeasured anions’ as an important component of human
metabolic acidosis. Sometimes these appear to be quanti-
tatively significantly more important than lactic acid itself. But
what is the nature of these unmeasured anions? We discuss
the evidence to date coupled with recent work from our
laboratory that may go some way in elucidating the nature of
these anions.
Identifying unmeasured anions
The presence of unmeasured anions contributing to meta-
bolic acidosis has been recognised for some time and as
early as 1963 Waters and colleagues, whilst discussing
lactic acidosis, hypothesised that under certain conditions
disturbances in acid-base balance may be “characterised by
the accumulation of an organic acid other than lactate” [8].
Furthermore, studies from Cohen’s group in London described
a case where hydroxybutyrate contributed significantly to an
observed metabolic acidosis of a non-diabetic patient [9].
The same group also demonstrated an elevation in succinate
levels in both hypoxic patients and perfused hypoxic canine
livers [10]. They proposed that disturbances in the oxidation
of succinate to oxaloacetate could account for this. Interest in
this area was rekindled by studies on critically ill patients in
which elevations in anion gap could not be accounted for
solely by increased lactate levels [11,12]. Further work
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examining the concentrations of other hitherto unmeasured
ions such as urate and phosphate as well as plasma proteins
could not account for the observed anion gap [13,14]. To try
to elucidate these species further, several workers have
employed animal models.
Animal studies
Some of the earliest studies that attempted to identify the
nature of the unmeasured anions were performed in animal
models. In 1990, Rackow and colleagues [15] assessed the
contribution of such species to the anion gap observed in
rats following caecal perforation. Compared to controls, the
septic animals demonstrated a metabolic acidosis with an
increase in plasma lactate and decrease in bicarbonate
concentrations. Only 15% of the anion gap observed could
be explained by lactate. The concentrations of pyruvate,
β-hydroxybutyrate, acetoacetate, citrate as well as some
amino acids were determined. No differences in these anions
could be detected between the study group and sham
animals. However, no detail as to the handling of the samples
was provided. These studies followed earlier work by Gossett
and colleagues [16] on critically ill horses with increased
anion gap acidosis. Again, the unexplained anion gap could
not be accounted for by pyruvate, β-hydroxybutyrate, aceto-
acetate, phosphate or albumin.
In other studies on diarrhoeic calves, the observed anion gap
was explained in part, but not completely, by the
accumulation of D-lactate [17]. To date, animal studies have,
therefore, provided little information as to the nature of the
unmeasured anions. Further animal work, employing a canine
model of sepsis, demonstrated that the liver released anions
into the circulation at a rate of 0.12 mEq/minute [18]. This
study also observed that the gut became a ‘consumer’ of
anions following development of endotoxaemia. Other canine
models have proposed that, in lactic acidosis, impaired
extraction of lactate by the liver coupled with increased
splanchnic production of lactate contributed to the
generation of the metabolic acidosis. Studies with humans,
however, do not support this view [19].
Studies on ICU patients
Pyroglutamic acidaemia
Pyroglutamic acidaemia is an inherited disorder presenting in
infancy due to a deficiency of either 5-oxoprolinase or gluta-
thione synthetase. Several case reports have described this
phenomenon occurring in adults, causing an elevated anion
gap acidosis often in association with drug administration
[20]. An early study of ICU patients described four patients in
whom pyroglutamic acid levels were noted to be elevated
[21]. The authors suggested that patients with this condition
be screened for obvious precipitants. However, a further
study examined pyroglutamic acid levels in 23 ICU patients
with metabolic acidosis and an unexplained increase in ion
gap. They found no correlation between the ion gap and
pyroglutamic acid levels and concluded that, in their
population, pyroglutamic acid could not account for the
unmeasured anions [22].
Krebs cycle intermediates
We recently attempted to identify the missing anions, arguing
that being negatively charged, they should reveal themselves
on negative ion mass spectrometry and should be at least
partially separable by ion exchange chromatography. There
was no predetermined view as to the likely nature of the
anions. Plasma from patients with various forms of metabolic
acidosis was examined. The patients were acidotic with an
average arterial pH of 7.18 (±0.11) and a base deficit of
13.4 mmol/l (±4.7) [23].
Figure 1 shows an ion exchange chromatogram/negative ion
mass spectrum of a plasma extract from a patient with
metabolic acidosis of unknown aetiology. This shows peaks
of relatively low mass that fitted those of known Krebs cycle
components. Standards of these anions proved to have
identical retention times to the plasma-derived peaks.
Interestingly, no ions attributable to other substances could
be seen apart from urate, which was also seen in control
samples. For comparison, we present the spectrum obtained
from a patient with diabetic ketoacidosis where the large
peaks attributable to acetoacetate and β-hydroxybutyrate are
clearly seen [24].
These preliminary results led us to examine the anions of the
Krebs cycle using enzyme assay (we also measured D-
lactate). Table 1 simplifies our results and, as can be seen,
plasma from patients with diabetic ketoacidosis showed
significant increases relative to the control values in α-
ketoglutarate, malate and D-lactate levels. However, citrate
and succinate concentrations were not elevated. In lactic
acidosis, increased concentrations of citrate, isocitrate, α-
ketoglutarate, succinate, malate and D-lactate were
observed. In patients with an acidosis of unknown origin
(acidosis disproportionate to the blood lactate
concentration), elevations in the concentrations of isocitrate,
α-ketoglutarate, succinate, malate and D-lactate were seen.
This observation that plasma concentrations of acids usually
associated with the Krebs tricarboxylic acid cycle are
significantly increased in patients with lactic acidosis as well
as those with ‘unexplained acidosis’ with normal or near
normal blood lactate concentrations may go some way to
addressing the ‘imbalance’ in the anion or strong ion gap.
In the main, these anions are effectively fully ionised at the
measured pH but, unlike lactate, they are not all monobasic,
with tribasic acids (citric and isocitric) contributing three
protons, whilst the dibasic acids (α-ketoglutaric, malic and
succinic) add two protons to the solution on ionisation. Our
study showed that, on average, the contribution to the
observed anion gap by such anions was regularly in excess of
3 mEq/l and, in some cases, over 5 mEq/l. Therefore, the role
of these anions in generating the anion gap is of muchPage 3 of 5
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greater significance than is apparent from their molarity. We
would stress that in data such as these, at least as much
attention should be given to the extreme values as to the
means.
From our preliminary work it became clear that rapid
separation of the plasma from red cells and also from its
proteins through centrifugation and ultrafiltration of the
samples together with prompt assay was vital. Even at –20°C
we observed steady degradation of the measured anions. The
most extreme example of the instability of these metabolic
intermediates is oxaloacetate, whose half-life in aqueous
solutions is so short that it is effectively unmeasurable [25].
D-lactate
Although we observed modest elevations in D-lactate
concentration in both diabetic and non-diabetic acidosis, this
never reached levels in these groups that would impact
significantly on the acid-base status of the patients. However,
in the patients with a normal anion gap acidosis, the level of
D-lactate was significantly raised. D-lactate is normally
present at nanomolar concentrations through the metabolism
Available online http://ccforum.com/content/10/4/220
Figure 1
Ion exchange chromatogram/negative ion mass spectra of plasma from a patient with diabetic ketoacidosis (top) and a patient with acidosis of
unknown aetiology (bottom). Liquid chromatography/electrospray ionisation mass spectrometry was performed on a Hewlett-Packard Series 1100
liquid chromatography system directly coupled to a Series 1100 Mass Spectrometer fitted with electrospray ionisation and operating in ‘negative
ion’ mode (Agilent Technologies UK Ltd, Wokingham, Berkshire, UK). The extracted ion currents are shown.
Table 1
Relative changes observed in Kreb's cycle intermediates and D-Lactate in patients with differing causes of acidosis
Acid DKA LA AUO NAG
Citrate – ?a ––
Isocitrate + +++ +++ –
α-Ketoglutarate +++ +++ +++ –
Succinate – +++ + –
Malate +++ +++ +++ –
D-lactate +++ +++ +++ +++
Dashes represent no significant difference from controls; a plus sign represents p < 0.02; three plus signs represent p < 0.001. aThis result may
be unreliable since four of the patients in this group had received an infusion of heparin (containing citrate as an anticoagulant) prior to the blood
sample being obtained. AUO, acidosis of unknown origin; DKA, diabetic ketoacidosis; LA lactic acidosis; NAG, normal anion gap acidosis.of methylglyoxal, although millimolar concentrations can be
observed through excess gastrointestinal metabolism and
elevated levels of D-lactate have been observed in critically ill
patients with intestinal ischaemia [26]. Interestingly, plasma
D-lactate levels have been proposed as an early potential
predictor of reduced 28 day ICU mortality [27] and has been
suggested as a tool for assessing colonic ischaemia in post
operative patients [28]. In rat models, however, D-lactate has
not been confirmed as a reliable marker of gut ischaemia
[29]. However, what is clear is that D-lactate may contribute
to metabolic acidosis and, in some cases, may contribute
significantly to the unmeasured anions.
Hydroxybutyrate
Another anion that does not fit neatly into this concept of
Krebs cycle acidaemia is hydroxybutyrate in non-diabetics.
We detected this anion in concentrations up to 4 mEq/l and,
as such, it could be a significant contributor to the un-
measured anions. We presumed that this was effectively a
marker for the metabolic changes of ‘starvation’ in the
patients in whom it was demonstrated, in agreement with
earlier studies [9].
Discussion
Many studies have highlighted the presence of unmeasured
anions in critically ill patients with metabolic acidosis,
although few have been successful in addressing their
chemical nature. The prognostic significance of unmeasured
anions is also a source of debate but recent studies seem to
suggest some predictive ability [30,31]. Certainly, the study
from Dondorp and colleagues [30] supports this view,
although the area under receiver operator curve for strong ion
gap toward mortality was just 0.73. However, all other
predictors also had values <0.8. Interestingly, recent studies
on the primary patho-physiological events of malarial infection
in animals revealed up-regulation of transcription of genes
that control host glycolysis [32]. One may speculate that the
unmeasured anions noted in severe malaria may, therefore,
be related to intermediary metabolism, in keeping with our
studies. Other workers have demonstrated the presence of
organic acids commonly associated with intermediary
metabolism under various conditions. Tricarboxylic acids have
been detected in human urine [33] and various organic acids
detected in the haemofiltrate of patients with acute renal
failure where the presence of elevated citrate levels was
loosely associated with a worse prognosis [34]. Furthermore,
citrate, malate and cis-aconitate have been detected in
patients with metabolic acidosis ascribed to salicylate
poisoning [35].
The results obtained from our work suggest that the role of
anions principally associated with the Krebs cycle in the
generation of the anion gap in ‘classic’ lactic acidosis may be
greater than previously thought and that these anions may
also have a significant role in the generation of the anion gap
in patients with acidosis of unknown cause. Their concentra-
tions did not differ significantly from control values in patients
with normal anion gap acidosis.
The likely source for the generation of these observed anions
is a matter of speculation and we have no direct evidence for
the site of production. Clearly, the mitochondria are one
possible source and the process could reflect mitochondrial
dysfunction, a concept that is currently an area of research in
critical care. It seems unlikely that the acidaemia per se is
responsible for the generation of increased levels of Krebs
intermediates given the normal values found in patients with
normal anion gap acidosis. It may reflect a physiological
response to a limitation in available oxygen supply and recent
work from our group has demonstrated increased levels of
Krebs cycle intermediates in normal subjects following severe
exercise [35].
The Krebs cycle functions not only as a ‘catalytic’ process in
intermediary metabolism but also as a source of substrates
for other metabolic pathways. For example, during protein
synthesis, α-ketoglutarate and oxaloacetate are removed from
the cycle to become aminated to glutamate and aspartate
(cataplerosis). This inevitably results in anaplerotic reactions,
ensuring continued function by replenishing tricarboxylic acid
intermediates. In gluconeogenesis, oxaloacetate is converted
to phosphoenolpyruvate and is lost to the Krebs cycle.
Lipogenesis requires the transfer of citrate from the
mitochondria to the cytosol as that is the site at which the
synthetic process occurs. In disease, the opposite is true;
anaplerotic reactions (those that generate rather than
consume Krebs cycle keto-acids) are likely to predominate.
Excess protein catabolism in particular will give rise to the
component amino acids. These approximately neutral
compounds are rapidly transaminated and/or deaminated to
form oxaloacetic acid, α-ketoglutaric and succinyl CoA
(effectively succinic acid), thereby potentially providing an
excess of acidic Krebs cycle components. There are few data
available from the critically ill on these processes. However,
under other conditions of stress, such as prolonged
starvation or extreme exercise [36], the levels of tricarboxylic
acid levels have been measured and it has been shown that
glutamine, for example, undergoes deamination (an ana-
plerotic process) to form α-ketoglutarate, which enters the
Krebs cycle and is sequentially converted to malate, which
then leaves the mitochondria. Malate is oxidized in the cytosol
to oxalocetate, which is in turn converted to phospho-
enolpyruvate.
Conclusion
The phenomenon of unexplained metabolic acidosis is well
recognised, as is the generation of ‘unexplained’ anions. Little
is known as to the nature of these species, although recent
studies suggest that anions usually associated with the Krebs
cycle may contribute to the observed anion or ‘strong-ion’
gap. Although these observations go no way to explaining
their genesis, they may provide the first glimpse of the
Critical Care    Vol 10 No 4 Forni et al.
Page 4 of 5
(page number not for citation purposes)underlying derangement in the metabolic acidosis associated
with ‘unmeasured anions’.
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